FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904143181> ?p ?o ?g. }

• W2904143181 endingPage "134" @default.
• W2904143181 startingPage "124" @default.
• W2904143181 abstract "The targeted delivery of therapeutics to sites of rheumatoid arthritis (RA) has been a long-standing challenge. Inspired by the intrinsic inflammation-targeting capacity of macrophages, a macrophage-derived microvesicle (MMV)-coated nanoparticle (MNP) was developed for targeting RA. The MMV was efficiently produced through a novel method. Cytochalasin B (CB) was applied to relax the interaction between the cytoskeleton and membrane of macrophages, thus stimulating MMV secretion. The proteomic profile of the MMV was analyzed by iTRAQ (isobaric tags for relative and absolute quantitation). The MMV membrane proteins were similar to those of macrophages, indicating that the MMV could exhibit bioactivity similar to that of RA-targeting macrophages. A poly(lactic-co-glycolic acid) (PLGA) nanoparticle was subsequently coated with MMV, and the inflammation-mediated targeting capacity of the MNP was evaluated both in vitro and in vivo. The in vitro binding of MNP to inflamed HUVECs was significantly stronger than that of the red blood cell membrane-coated nanoparticle (RNP). Compared with bare NP and RNP, MNP showed a significantly enhanced targeting effect in vivo in a collagen-induced arthritis (CIA) mouse model. The targeting mechanism was subsequently revealed according to the proteomic analysis, indicating that Mac-1 and CD44 contributed to the outstanding targeting effect of the MNP. A model drug, tacrolimus, was encapsulated in MNP (T-RNP) and significantly suppressed the progression of RA in mice. The present study demonstrates MMV as a promising and rich material, with which to mimic macrophages, and demonstrates that MNP is an efficient biomimetic vehicle for RA targeting and treatment." @default.
• W2904143181 created "2018-12-22" @default.
• W2904143181 creator A5005132140 @default.
• W2904143181 creator A5032447955 @default.
• W2904143181 creator A5035093874 @default.
• W2904143181 creator A5040730790 @default.
• W2904143181 creator A5041205100 @default.
• W2904143181 creator A5066476209 @default.
• W2904143181 creator A5067764982 @default.
• W2904143181 creator A5071314083 @default.
• W2904143181 creator A5074706280 @default.
• W2904143181 creator A5079169653 @default.
• W2904143181 creator A5086318213 @default.
• W2904143181 date "2018-12-06" @default.
• W2904143181 modified "2023-10-16" @default.
• W2904143181 title "Route to Rheumatoid Arthritis by Macrophage-Derived Microvesicle-Coated Nanoparticles" @default.
• W2904143181 cites W1133046639 @default.
• W2904143181 cites W145753889 @default.
• W2904143181 cites W1708766730 @default.
• W2904143181 cites W1711619332 @default.
• W2904143181 cites W1973831032 @default.
• W2904143181 cites W1980052502 @default.
• W2904143181 cites W1981153918 @default.
• W2904143181 cites W1993337563 @default.
• W2904143181 cites W2002329505 @default.
• W2904143181 cites W2019981382 @default.
• W2904143181 cites W2024644107 @default.
• W2904143181 cites W2039949492 @default.
• W2904143181 cites W2053929414 @default.
• W2904143181 cites W2064346787 @default.
• W2904143181 cites W2065764124 @default.
• W2904143181 cites W2070593611 @default.
• W2904143181 cites W2073765250 @default.
• W2904143181 cites W2074438676 @default.
• W2904143181 cites W2077129199 @default.
• W2904143181 cites W2090947374 @default.
• W2904143181 cites W2091697975 @default.
• W2904143181 cites W2101305511 @default.
• W2904143181 cites W2104418998 @default.
• W2904143181 cites W2110826367 @default.
• W2904143181 cites W2115004354 @default.
• W2904143181 cites W2123333870 @default.
• W2904143181 cites W2124097898 @default.
• W2904143181 cites W2131093613 @default.
• W2904143181 cites W2133692536 @default.
• W2904143181 cites W2145479354 @default.
• W2904143181 cites W2146607274 @default.
• W2904143181 cites W2164557053 @default.
• W2904143181 cites W2273452210 @default.
• W2904143181 cites W2293176103 @default.
• W2904143181 cites W2313248184 @default.
• W2904143181 cites W2319957449 @default.
• W2904143181 cites W2328007970 @default.
• W2904143181 cites W2340084730 @default.
• W2904143181 cites W2406375428 @default.
• W2904143181 cites W2478711226 @default.
• W2904143181 cites W2593910260 @default.
• W2904143181 cites W2624985846 @default.
• W2904143181 cites W2779494670 @default.
• W2904143181 cites W2780622257 @default.
• W2904143181 cites W2794683780 @default.
• W2904143181 cites W2799271795 @default.
• W2904143181 cites W286204498 @default.
• W2904143181 cites W2889191136 @default.
• W2904143181 cites W989479261 @default.
• W2904143181 doi "https://doi.org/10.1021/acs.nanolett.8b03439" @default.
• W2904143181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30521345" @default.
• W2904143181 hasPublicationYear "2018" @default.
• W2904143181 type Work @default.
• W2904143181 sameAs 2904143181 @default.
• W2904143181 citedByCount "182" @default.
• W2904143181 countsByYear W29041431812019 @default.
• W2904143181 countsByYear W29041431812020 @default.
• W2904143181 countsByYear W29041431812021 @default.
• W2904143181 countsByYear W29041431812022 @default.
• W2904143181 countsByYear W29041431812023 @default.
• W2904143181 crossrefType "journal-article" @default.
• W2904143181 hasAuthorship W2904143181A5005132140 @default.
• W2904143181 hasAuthorship W2904143181A5032447955 @default.
• W2904143181 hasAuthorship W2904143181A5035093874 @default.
• W2904143181 hasAuthorship W2904143181A5040730790 @default.
• W2904143181 hasAuthorship W2904143181A5041205100 @default.
• W2904143181 hasAuthorship W2904143181A5066476209 @default.
• W2904143181 hasAuthorship W2904143181A5067764982 @default.
• W2904143181 hasAuthorship W2904143181A5071314083 @default.
• W2904143181 hasAuthorship W2904143181A5074706280 @default.
• W2904143181 hasAuthorship W2904143181A5079169653 @default.
• W2904143181 hasAuthorship W2904143181A5086318213 @default.
• W2904143181 hasConcept C104317684 @default.
• W2904143181 hasConcept C12554922 @default.
• W2904143181 hasConcept C145059251 @default.
• W2904143181 hasConcept C150903083 @default.
• W2904143181 hasConcept C185592680 @default.
• W2904143181 hasConcept C202751555 @default.
• W2904143181 hasConcept C203014093 @default.
• W2904143181 hasConcept C20518536 @default.
• W2904143181 hasConcept C207001950 @default.
• W2904143181 hasConcept C2776914184 @default.

• next